Below, Ill explain how GLP-1 medications may work, what can influence response time, and why provider monitoring matters throughout treatment
Regarding treatment strategies, it is suggested that the marked decrease in GPx1 expression may be the major mechanism of tumor sensitization to anthracyclines [93] and that GPx1 can partially inhibit doxorubicin-induced cell death-related signaling in breast cancer by interfering with the activation of the sphingomyelin-ceramide pathway [85]
In addition, real-world use is frequently confounded by co-administration of multiple agents and inconsistent sourcing, limiting external validity and complicating attribution of benefit or harm
With over 40% of US adults classified as obese and 11.3% living with diabetes, GLP-1 treatments offer a powerful tool to improve long-term health
In 2006, the U.S
Some commonly reported side effects of DPP-4 inhibitors noted in clinical trials include upper respiratory tract infection, urinary tract infection (UTI), nasopharyngitis, and headache ( Table 3 )